Clinical Trials Directory

Trials / Completed

CompletedNCT01024699

XLIF® vs. MAS®TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenosis.

A Prospective Multi-Center Randomized Evaluation of the Clinical and Radiographic Outcomes of XLIF® Compared With MAS® TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenosis

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
NuVasive · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine differences in the XLIF and TLIF procedures with respect to perioperative variables in adult patients with low-grade symptomatic spondylolisthesis.

Detailed description

The study is a prospective multi-center randomized evaluation of clinical and radiographic outcomes of two commonly used lumbar interbody fusion procedures (XLIF and TLIF) in adult patients with low-grade symptomatic spondylolisthesis. The study seeks to identify differences between the procedures with respect to perioperative variables.

Conditions

Timeline

Start date
2009-11-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2009-12-03
Last updated
2025-12-24

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01024699. Inclusion in this directory is not an endorsement.

XLIF® vs. MAS®TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenos (NCT01024699) · Clinical Trials Directory